Dati regionali e loro ruolo nella pianificazione, nella programmazione e nel controllo a livello regionale

Glob Reg Health Technol Assess. 2024 Apr 25:11:101-104. doi: 10.33393/grhta.2024.3024. eCollection 2024 Jan-Dec.
[Article in Italian]

Abstract

Regional administrative data may help public administrations in organizing their information, identifying problems, defining solutions and verifying results of the actions taken.

The objective of this work is to present the discussion output of the working group (GDL) “The use of regional pharmaceutical data to facilitate health planning and outcome monitoring” which was held during the Regional Pharmaceutical Policy Forum of 2023.

The GDL focused on identifying a model for planning, programming and monitoring health resources based on the data-driven approach and on the use of already existing regional administrative data, defining some gaps and developing proposals to implement this strategy. In particular, were highlighted the needs to adopt a broader perspective that considers healthcare costs as a whole (and not, specifically, oriented towards the governance of pharmaceutical assistance), to create ad-hoc training courses focused on the use of real-world data, and, similarly to some European Countries, to move towards an open access policy (accessible data) that can be useful to improve citizens’ health protection services, in compliance with the GDPR.

Grants and funding

Conflict of interest: IM, PS and GC, declare no conflict of interest; GT participated to advisory boards on topics not related to this paper and sponsored by Eli Lilly; Sanofi; Amgen; Novo Nordisk; Sobi; Gilead; Celgene; Daikii Sankyo; he acted as scientific coordinator of the academic spin-off INSPIRE for observational studies/systematic reviews on rare diseases funded by PTC Pharmaceutics, Kiowa Kirin, Novo Nordisk, Shonogi and Shire and on topics not related to this paper.